Back to Search Start Over

[123I]Ioflupane SPECT in the assessment of Parkinson's disease in a patient with retinitis pigmentosa.

Authors :
Dondi, Francesco
Gregorelli, Michela
Albano, Domenico
Bertagna, Francesco
Giubbini, Raffaele
Source :
Nuclear Medicine Review; 2023, Vol. 26, p34-35, 2p
Publication Year :
2023

Abstract

Retinis pigmentosa is a form of retinal dystrophy characterized by pigment deposition resulting in loss of peripheral vision, tunnel vision, night blindness and in some cases full blindness. Parkinson's disease is a progressive extrapyramidal neurological disorder characterized by rigidity, bradykinesia and tremor at rest due to loss of substantia nigra's dopaminergic cell; this loss can be evaluated with [<superscript>123</superscript>I]Ioflupane single-photon emission computed tomography (SPECT). There are growing evidences underlying a possible correlation between these two conditions; in this report we describe a patient affected by retinitis pigmentosa with a positive [123I]Ioflupane scan underlying a possible connection with Parkinson's disease. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15069680
Volume :
26
Database :
Complementary Index
Journal :
Nuclear Medicine Review
Publication Type :
Academic Journal
Accession number :
164665572
Full Text :
https://doi.org/10.5603/NMR.a2022.0040